↓ Skip to main content

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
53 Mendeley
Title
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
Published in
Cancer Immunology, Immunotherapy, August 2019
DOI 10.1007/s00262-019-02376-y
Pubmed ID
Authors

Stefanie Koristka, Pauline Ziller-Walter, Ralf Bergmann, Claudia Arndt, Anja Feldmann, Alexandra Kegler, Marc Cartellieri, Armin Ehninger, Gerhard Ehninger, Martin Bornhäuser, Michael P. Bachmann

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 25%
Student > Ph. D. Student 10 19%
Student > Master 8 15%
Student > Bachelor 3 6%
Student > Doctoral Student 3 6%
Other 6 11%
Unknown 10 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 25%
Immunology and Microbiology 9 17%
Medicine and Dentistry 5 9%
Agricultural and Biological Sciences 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Other 8 15%
Unknown 11 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2022.
All research outputs
#6,112,971
of 23,025,074 outputs
Outputs from Cancer Immunology, Immunotherapy
#849
of 2,895 outputs
Outputs of similar age
#107,810
of 342,266 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#7
of 37 outputs
Altmetric has tracked 23,025,074 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 2,895 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,266 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.